Abstract
Anticarcinogenic effects attributed to phytochemicals may be based on synergistic, additive, or antagonistic interactions of many compounds. In our previous study, we demonstrated that the chloroform fraction (CHCl(3)-F) from Z. jujuba has anticancer activity in HepG2 cells. In China, many people drink jujuba tea and believe in the synergic effects of jujuba and tea for better health. We therefore investigated the effects of CHCl(3)-F and green tea extract (GTE), and their underlying mechanisms of action in HepG2 cells. Our results showed that GTE enhanced the effect of CHCl(3)-F on cell viability in HepG2 cells, without cytotoxicity in rat hepatocytes, which was used as a normal cell model. Furthermore, combination of CHCl(3)-F and GTE caused an effect on G1 phase arrest but not on apoptosis. Interestingly, the mechanism of the G1 arrest was associated, not with an increase in p27(Kip1) levels and the hypohosphorylation of Rb, which are pathways used by CHCl(3)-F on G1 arrest in HepG2 cells, but with increases in p53 and p21(Waf1/Cip1) levels, and a decrease in cyclin E levels. Collectively, our findings suggest that combination of CHCl(3)-F and GTE produces an enhanced cell growth inhibition effect, and that the resultant G1 ...Continue Reading
References
May 7, 1976·Analytical Biochemistry·M M Bradford
Jun 1, 1986·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R J RiddellM Balls
Apr 1, 1995·Molecular Biology of the Cell·J W HarperE Swindell
May 5, 1995·Cell·R A Weinberg
May 1, 1995·Molecular and Cellular Biology·H HiraiC J Sherr
Feb 1, 1993·Current Opinion in Genetics & Development·M E Perry, A J Levine
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·J B SchnierE M Bradbury
Aug 1, 1996·Molecular and Cellular Biology·K M LathamP W Hinds
Apr 4, 1998·American Journal of Respiratory Cell and Molecular Biology·H AdachiA M Jetten
Aug 27, 1999·Journal of Cellular Biochemistry·Y C LiangJ K Lin
Mar 18, 2000·The Journal of Nutrition·C S YangM J Lee
Nov 4, 2000·Expert Opinion on Investigational Drugs·H K Wang
Mar 7, 2002·Cancer Letters·Igor B Roninson
Mar 7, 2002·Cancer Letters·David Opare KennedyIsao Matsui-Yuasa
Apr 23, 2003·European Journal of Pharmacology·Hsu-Chin ChanShih-Lan Hsu
Jul 26, 2003·Journal of Natural Products·David J NewmanKenneth M Snader
Oct 8, 2003·Planta medica·Mu ZhangXiaoxiang Zheng
Feb 18, 2004·Current Cancer Drug Targets·S MazumderA Almasan
Jun 19, 2004·Anti-cancer Drugs·Masahiro AsakageHirokazu Nagawa
Dec 4, 2004·Chemical & Pharmaceutical Bulletin·Mourboul AbliseSophie Visvikis
Sep 1, 2005·Cancer Letters·Dorothy M Morré, D James Morré
Feb 7, 2006·Journal of Chromatography. a·J ZhaoY T Wang
May 9, 2007·Bioscience, Biotechnology, and Biochemistry·Saeda KametaniIsao Matsui-Yuasa
Jun 29, 2007·The American Journal of Chinese Medicine·Xuedan HuangIsao Matsui-Yuasa
Aug 29, 2007·Psychosomatic Medicine·Wendy M TroxelDaniel J Buysse
Aug 31, 2007·Molecular Ecology·Jessica L MetcalfAndrew P Martin
Dec 25, 2007·American Journal of Reproductive Immunology : AJRI·Shehzad M Iqbal, Rupert Kaul
Citations
Jun 9, 2009·Phytotherapy Research : PTR·Hwa Jung ChoiSeung Hwa Baek
Mar 16, 2016·Nutrients·Yue ZhouHua-Bin Li
Feb 4, 2012·Journal of Ethnopharmacology·Pierluigi PlastinaBartolo Gabriele
Feb 18, 2009·The American Journal of Chinese Medicine·Xuedan HuangIsao Matsui-Yuasa
Feb 4, 2010·The American Journal of Chinese Medicine·Fa-Rong YuFa-Hong Yu
Jul 17, 2009·The American Journal of Chinese Medicine·Hiroaki KubotaIsao Matsui-Yuasa
Sep 24, 2020·Food & Function·Shuhua ShanZhuoyu Li
Oct 22, 2015·Diseases·Akiko Kojima-YuasaIsao Matsui-Yuasa
Sep 10, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bassem Y SheikhAmin Ismail